These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 6257257)

  • 1. Effects of dopaminergic receptor stimulation and opioid receptor blockade on GH incretion: preliminary findings.
    Ghisoli E; Benfenati F; Pancaldi L; Meringolo D; Catenacci M
    Boll Soc Ital Biol Sper; 1980 Jun; 56(12):1222-5. PubMed ID: 6257257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Naloxone potentiation of 2-Br-alpha-ergocryptine (CB 154) effects on GH secretion in man.
    Agnati LF; D'Alessandro R; Benfenati F; Cortelli P; Galassi E; Capelli M
    Neurosci Lett; 1979 Dec; 15(2-3):229-33. PubMed ID: 231241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormal control of growth hormone secretion by opiate systems in acromegalic patients: a study with naloxone and 2-Br-alpha-ergocryptine (CB 154).
    Agnati LF; Benfenati F; Frank G; Capelli M; Bernardi P; Calza L
    Med Biol; 1981 Feb; 59(1):58-63. PubMed ID: 7266088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Partial blockade by naloxone of clonidine-induced increase in plasma growth hormone in hypertensive patients.
    Bramnert M; Hökfelt B
    J Clin Endocrinol Metab; 1984 Feb; 58(2):374-7. PubMed ID: 6319449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic bromocriptine administration restores luteinizing hormone response to naloxone in postmenopausal women.
    Melis GB; Cagnacci A; Gambacciani M; Paoletti AM; Caffi T; Fioretti P
    Neuroendocrinology; 1988 Feb; 47(2):159-63. PubMed ID: 2830551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth hormone, prolactin and cortisol nyctohemeral variations during naloxone-induced opiate receptor blockade in man.
    Delitala G; Giusti M; Rodriguez G; Mazzocchi G; Ferrini S; Baccelliere L; Montano V; Rosadini G; Giordano G
    Acta Endocrinol (Copenh); 1982 Jul; 100(3):321-6. PubMed ID: 6287782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of opiate receptor blockade with naloxone on thyrotropin secretion in heart transplant patients.
    Gumprecht J; Zembala M; Zukowska-Szczechowska E; Grzeszczak W; Religa Z; Moczulski D; Wojarski J
    Transplant Proc; 1996 Dec; 28(6):3540-1. PubMed ID: 8962375
    [No Abstract]   [Full Text] [Related]  

  • 8. Dynorphin A1-13 causes elevation of serum levels of prolactin through an opioid receptor mechanism in humans: gender differences and implications for modulation of dopaminergic tone in the treatment of addictions.
    Kreek MJ; Schluger J; Borg L; Gunduz M; Ho A
    J Pharmacol Exp Ther; 1999 Jan; 288(1):260-9. PubMed ID: 9862779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of dopaminergic receptors in the regulation of growth hormone secretion.
    Müller EE; Liuzzi A; Cocchi D; Panerai AE; Oppizzi G; Lacatelli V; Mantegazza P; Silvestrini F; Chiodini PG
    Adv Biochem Psychopharmacol; 1977; 16():127-38. PubMed ID: 142419
    [No Abstract]   [Full Text] [Related]  

  • 10. Volume-regulated arginine vasopressin release in conscious dogs. Evidence for dopaminergic or opioid modulation?
    Hellebrekers LJ; Lagerweij E; de Vries HW; van Wimersma Greidanus TB
    Acta Endocrinol (Copenh); 1988 Sep; 119(1):106-12. PubMed ID: 2842992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopaminergic inhibition of metoclopramide-induced aldosterone secretion in man. Dissociation of responses to dopamine and bromocriptine.
    Carey RM; Thorner MO; Ortt EM
    J Clin Invest; 1980 Jul; 66(1):10-8. PubMed ID: 7400305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for opiate and estrogen interaction on neurohormonal secretion.
    Steardo L; Monteleone P; Scopacasa F
    Acta Neurol (Napoli); 1983 Jun; 5(3):165-73. PubMed ID: 6310976
    [No Abstract]   [Full Text] [Related]  

  • 13. Differential influence of D1 and D2 dopamine receptors on acute opiate withdrawal in guinea-pig isolated ileum.
    Capasso A; Sorrentino L
    Br J Pharmacol; 1997 Mar; 120(6):1001-6. PubMed ID: 9134209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antagonism by naloxone of anti-tremorine effect of bromocriptine in mice.
    Shukla VK; Garg SK; Kulkarni SK
    Methods Find Exp Clin Pharmacol; 1987 May; 9(5):303-6. PubMed ID: 3613759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The lack of affinity of prostaglandins to dopaminergic and opiate receptors in the rat striatum.
    Członkowski A; Herman Z
    Pol J Pharmacol Pharm; 1980; 32(5):639-41. PubMed ID: 6267565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating concentrations of luteinizing hormone, testosterone, and growth hormone after naloxone treatment in sexually mature boars.
    Estienne MJ; Harper AF; Knight JW; Rampacek GB; Barb CR
    Reprod Biol; 2002 Jul; 2(2):133-42. PubMed ID: 14666154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Presynaptic opiate receptor-mediated inhibition of endogenous norepinephrine and dopamine-beta-hydroxylase release in the cat spleen, independent of the presynaptic alpha adrenoceptors.
    Gaddis RR; Dixon WR
    J Pharmacol Exp Ther; 1982 Oct; 223(1):77-83. PubMed ID: 6288922
    [No Abstract]   [Full Text] [Related]  

  • 18. Growth hormone and changes in the secretion of thyrotropic hormone after thyrotropin-releasing hormone (TRH): ineffectiveness of dopaminergic stimulation.
    Felt V; Nedvídková J
    Endokrinologie; 1982 Oct; 80(2):201-6. PubMed ID: 6819130
    [No Abstract]   [Full Text] [Related]  

  • 19. Analgesic effects of 3-methoxybenzamide in rats.
    Sanders R; Dill RE; Dorris RL; Miller EG
    J Pharm Pharmacol; 1989 Apr; 41(4):268-9. PubMed ID: 2568469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions among mu- and delta-opioid receptors, especially putative delta1- and delta2-opioid receptors, promote dopamine release in the nucleus accumbens.
    Hirose N; Murakawa K; Takada K; Oi Y; Suzuki T; Nagase H; Cools AR; Koshikawa N
    Neuroscience; 2005; 135(1):213-25. PubMed ID: 16111831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.